NBIX: Neurocrine Biosciences, Inc. Stock

by  •  • Comments Off on NBIX: Neurocrine Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 11,576.58
Enterprise Value ($M) 10,500.48
Book Value ($M) 2,589.70
Book Value / Share 25.97
Price / Book 4.47
NCAV ($M) 595.70
NCAV / Share 5.97
Price / NCAV 19.43

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 3.28
Current Ratio 3.40

Balance Sheet (mrq) ($M)
Current Assets 1,724.70
Assets 3,718.70
Liabilities 1,129.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,355.30
Operating Income 583.00
Net Income 341.30
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 595.40
Cash from Investing -126.80
Cash from Financing -486.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G State Street Corp
2024-02-13 13G/A Vanguard Group Inc 9.88 3.96
2024-01-23 13G/A BlackRock, Inc. 13.90 8.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 445,671 1,617,356 27.56
2025-02-20 243,050 1,007,384 24.13
2025-02-19 169,781 710,292 23.90
2025-02-18 243,796 817,002 29.84

(click for more detail)

Similar Companies
MRSN – Mersana Therapeutics, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MYGN – Myriad Genetics, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc.


Financial data and stock pages provided by
Fintel.io